{
    "2021-11-29": [
        [
            {
                "time": "2021-11-30",
                "original_text": "Merck Shares Fall Ahead of FDA Hearing on Covid Pill",
                "features": {
                    "keywords": [
                        "Merck",
                        "Shares",
                        "Fall",
                        "FDA",
                        "Covid",
                        "Pill"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-11-30",
                "original_text": "US STOCKS-Wall Street rebounds after virus-related sell-off",
                "features": {
                    "keywords": [
                        "US",
                        "STOCKS",
                        "Wall",
                        "Street",
                        "rebounds",
                        "virus-related",
                        "sell-off"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-30",
                "original_text": "Omicron stock market rout doesn't mean stocks are a 'screaming' buy: strategist",
                "features": {
                    "keywords": [
                        "Omicron",
                        "stock",
                        "market",
                        "rout",
                        "strategist"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-30",
                "original_text": "Dow Jones Jumps 300 Points As Stock Market Rebounds From Friday Rout",
                "features": {
                    "keywords": [
                        "Dow",
                        "Jones",
                        "Jumps",
                        "Stock",
                        "Market",
                        "Rebounds",
                        "Friday",
                        "Rout"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-30",
                "original_text": "BioNTech, Pfizer, J&J and Moderna Developing Omicron Vaccines",
                "features": {
                    "keywords": [
                        "BioNTech",
                        "Pfizer",
                        "J&J",
                        "Moderna",
                        "Developing",
                        "Omicron",
                        "Vaccines"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-11-30",
                "original_text": "Another COVID wave could depress consumer spending, labor force participation: Economist",
                "features": {
                    "keywords": [
                        "COVID",
                        "wave",
                        "consumer",
                        "spending",
                        "labor",
                        "force",
                        "participation",
                        "Economist"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "economy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-11-30",
                "original_text": "Vaccine Stocks Could Win Now, Lose Later, From the Omicron Variant",
                "features": {
                    "keywords": [
                        "Vaccine",
                        "Stocks",
                        "Win",
                        "Lose",
                        "Omicron",
                        "Variant"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}